Creas F&C Co.,Ltd (KOSDAQ:110790)
South Korea · Delayed Price · Currency is KRW 4,680.00
+5.00 (0.11%)
At close: Aug 7, 2025
Revance Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 383,434 | 331,280 | 367,043 | 380,917 | 375,939 | 292,422 | Upgrade |
Other Revenue | -0 | - | -0 | - | - | - | Upgrade |
| 383,434 | 331,280 | 367,043 | 380,917 | 375,939 | 292,422 | Upgrade | |
Revenue Growth (YoY) | 4.99% | -9.74% | -3.64% | 1.32% | 28.56% | 12.71% | Upgrade |
Cost of Revenue | 181,436 | 128,760 | 121,026 | 104,339 | 110,674 | 101,576 | Upgrade |
Gross Profit | 201,998 | 202,520 | 246,017 | 276,578 | 265,265 | 190,846 | Upgrade |
Selling, General & Admin | 179,322 | 178,690 | 188,989 | 188,333 | 170,215 | 134,205 | Upgrade |
Other Operating Expenses | 2,116 | 1,852 | 1,816 | 1,482 | 914.41 | 754.57 | Upgrade |
Operating Expenses | 192,409 | 190,653 | 199,405 | 198,090 | 178,162 | 140,856 | Upgrade |
Operating Income | 9,589 | 11,867 | 46,612 | 78,488 | 87,103 | 49,989 | Upgrade |
Interest Expense | -11,550 | -11,423 | -10,226 | -5,177 | -675.18 | -619.12 | Upgrade |
Interest & Investment Income | 1,062 | 1,337 | 1,526 | 752.72 | 433.88 | 355.03 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -221.02 | 216.11 | Upgrade |
Currency Exchange Gain (Loss) | -573.49 | 32.82 | 78.21 | -967.78 | -560.82 | -158.29 | Upgrade |
Other Non Operating Income (Expenses) | 8,399 | 4,809 | 33.8 | -26,140 | 1,769 | 119.89 | Upgrade |
EBT Excluding Unusual Items | 6,927 | 6,623 | 38,024 | 46,956 | 87,849 | 49,903 | Upgrade |
Gain (Loss) on Sale of Investments | -4,561 | -19,238 | -281.87 | -6,905 | 370.43 | 1,643 | Upgrade |
Gain (Loss) on Sale of Assets | 1,099 | -644.25 | 423.4 | 771.24 | -532.72 | -547.14 | Upgrade |
Asset Writedown | -10,299 | -9,955 | -3,242 | - | - | - | Upgrade |
Other Unusual Items | -3,147 | -3,094 | - | - | - | - | Upgrade |
Pretax Income | -9,981 | -26,309 | 34,924 | 40,822 | 87,686 | 50,998 | Upgrade |
Income Tax Expense | -308.47 | -1,169 | 11,691 | 14,459 | 19,555 | 12,379 | Upgrade |
Earnings From Continuing Operations | -9,672 | -25,140 | 23,233 | 26,363 | 68,131 | 38,619 | Upgrade |
Net Income to Company | -9,672 | -25,140 | 23,233 | 26,363 | 68,131 | 38,619 | Upgrade |
Minority Interest in Earnings | -106.42 | - | 940.42 | 336.97 | 161.19 | 52.22 | Upgrade |
Net Income | -9,779 | -25,140 | 24,173 | 26,700 | 68,293 | 38,671 | Upgrade |
Net Income to Common | -9,779 | -25,140 | 24,173 | 26,700 | 68,293 | 38,671 | Upgrade |
Net Income Growth | - | - | -9.46% | -60.90% | 76.60% | 55.75% | Upgrade |
Shares Outstanding (Basic) | 21 | 21 | 21 | 22 | 22 | 22 | Upgrade |
Shares Outstanding (Diluted) | 21 | 21 | 25 | 24 | 22 | 22 | Upgrade |
Shares Change (YoY) | -11.66% | -16.37% | 1.07% | 11.11% | -1.17% | -4.52% | Upgrade |
EPS (Basic) | -475.56 | -1222.33 | 1137.13 | 1227.38 | 3148.55 | 1745.30 | Upgrade |
EPS (Diluted) | -554.56 | -1222.33 | 1090.78 | 1168.49 | 3126.78 | 1745.30 | Upgrade |
EPS Growth | - | - | -6.65% | -62.63% | 79.15% | 63.13% | Upgrade |
Free Cash Flow | -36,672 | -32,374 | -13,521 | -129,647 | 28,868 | 51,015 | Upgrade |
Free Cash Flow Per Share | -1783.41 | -1574.08 | -549.79 | -5328.21 | 1318.27 | 2302.40 | Upgrade |
Dividend Per Share | 200.000 | 200.000 | 300.000 | 250.000 | 500.000 | - | Upgrade |
Dividend Growth | -33.33% | -33.33% | 20.00% | -50.00% | - | - | Upgrade |
Gross Margin | 52.68% | 61.13% | 67.03% | 72.61% | 70.56% | 65.26% | Upgrade |
Operating Margin | 2.50% | 3.58% | 12.70% | 20.61% | 23.17% | 17.09% | Upgrade |
Profit Margin | -2.55% | -7.59% | 6.59% | 7.01% | 18.17% | 13.23% | Upgrade |
Free Cash Flow Margin | -9.56% | -9.77% | -3.68% | -34.03% | 7.68% | 17.45% | Upgrade |
EBITDA | 20,992 | 21,890 | 56,019 | 86,724 | 94,136 | 56,041 | Upgrade |
EBITDA Margin | 5.47% | 6.61% | 15.26% | 22.77% | 25.04% | 19.16% | Upgrade |
D&A For EBITDA | 11,404 | 10,023 | 9,407 | 8,236 | 7,032 | 6,051 | Upgrade |
EBIT | 9,589 | 11,867 | 46,612 | 78,488 | 87,103 | 49,989 | Upgrade |
EBIT Margin | 2.50% | 3.58% | 12.70% | 20.61% | 23.17% | 17.09% | Upgrade |
Effective Tax Rate | - | - | 33.48% | 35.42% | 22.30% | 24.27% | Upgrade |
Advertising Expenses | - | 22,379 | 23,493 | 22,240 | 16,406 | 16,136 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.